Published in Drug Law Weekly, February 8th, 2005
Study 1: A scientist reports 'out points' criteria for breast implant removal without replacement and criteria to minimize reoperations following breast augmentation in a recent issue of Plastic and Reconstructive Surgery.
"Breast augmentation is a totally elective, medically unnecessary procedure, and surgeons and patients must prioritize minimizing tradeoffs, costs, and risks at the primary operation and at reoperations. At the U.S. Food and Drug Administration's advisory panel hearings in October of 2003 to consider approval of conventional silicone gel...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.